Status:
RECRUITING
Genetic Predisposition in Cerebral Palsy
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cerebral Palsy
Eligibility:
All Genders
2-15 years
Phase:
NA
Brief Summary
Cerebral palsy (CP) is a major neurodevelopmental disorder with an estimated prevalence of approximately one in 500 children. It is characterised by permanent developmental disorders of movement and p...
Eligibility Criteria
Inclusion
- Child between 2 and 15 years old with a clinical diagnostic of cerebral paralysis with unilateral or bilateral somatic involvement
- Child born from 34 SA
- Agreement of the legal representatives for the genetic study
- Both parents available for a parental genetic study (if detection of class 3 variant)
- Affiliation to the social security system
Exclusion
- Genetic syndrome identified or malformative or infectious etiologies identified
- Neonatal encephalopathy criteria in a clear obstetrical etiological context responsible for major perinatal anoxia with Sarnat 2 or 3
- Unilateral motor disorders in perinatal stroke of identified etiology (coagulation anomaly)
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 8 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05317234
Start Date
September 8 2023
End Date
March 8 2028
Last Update
March 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Médecine Physique et Réadaptation Pédiatrique - Hôpital Femme-Mère-Enfant
Bron, France, 69677
2
Service de médecine physique et réadaptative pédiatrique, Pôle pédiatrie-Génétique - Hôpital Couple-Enfant
Grenoble, France